Palomar (PLMR) Q1 2026 Earnings Transcript

Palomar Holdings reported Q1 2026 adjusted net income of $63.1 million, or $2.31 per share, up 23% year over year, while gross written premiums rose 42% to $629.8 million and adjusted net income guidance was raised to $262 million-$278 million. The company also posted a 26.6% adjusted ROE, completed a $410 million catastrophe bond, and authorized a new $200 million buyback after repurchasing $23.1 million of stock in the quarter. Offsetting the strong results, the adjusted combined ratio worsened to 76% from 68.5% and management flagged continued pricing pressure in commercial earthquake and some property lines.

Analysis

PLMR is behaving less like a cyclical insurer and more like a compounding capital-allocation story with underwriting embedded optionality. The key second-order effect is that higher retention plus better reinsurance economics increases the earnings leverage of every incremental premium dollar, so top-line growth is now translating into faster-than-expected book value accretion even while management is deliberately pruning weaker lines. That makes the business unusually resilient if the current softening in selected property and casualty niches persists, because they can simply reweight into better spreads rather than chase volume.

The market is likely underappreciating how much of the growth is now coming from lines that are either counter-cyclical or self-reinforcing: crop, surety, residential quake, and builder’s risk/data center adjacency. Those businesses are not just diversifying revenue; they also improve distribution relevance and deepen broker relationships, which should lower customer acquisition costs and increase cross-sell over time. The AI initiative matters here less as a headline and more as an expense-ratio flywheel: in a regulated specialty insurer, small workflow improvements across underwriting and claims can produce outsized margin durability because they compound on a high-retention, low-loss-volatility base.

The main risk is not a near-term earnings miss; it is an accumulation of seemingly manageable underwriting choices that look benign in a benign loss environment. Casualty reserve conservatism is supportive today, but the book is still young enough that a few accident years can reprice the narrative quickly if severity trends worsen or if the company keeps leaning into adjacent programs. Similarly, the buyback is value-accretive only if underwriting discipline holds; if management starts using repurchases to mask slowing organic growth, the multiple should compress. The catalyst path remains over the next 2-4 quarters: sustained reserve releases, continued retention gains, and evidence that higher net retention is not inflating tail risk.

Key Decisions for Investors

• Long PLMR on a 6-12 month horizon; prefer adding on broad insurance selloffs rather than chasing strength. Risk/reward remains favorable if management can keep ROE above 20% and convert premium growth into BVPS acceleration.
• Pair trade: long PLMR / short a lower-quality specialty P&C peer with weaker growth and higher cat sensitivity. The spread should widen if the market rewards capital efficiency over headline combined ratio optics.
• Use call spreads on PLMR for the next 2-3 quarters rather than outright stock if valuation is already rich; upside is driven by repeated guidance raises, while downside is protected by buybacks and balance-sheet strength.
• Monitor casualty loss emergence and reserve development over the next 2 earnings prints; if attritional losses start outpacing premium growth, reduce exposure quickly because the equity story is heavily confidence-based.
• If PLMR retraces on any temporary softening in earthquake pricing, buy the dip only if retention stays near current levels; if retention slips, the thesis breaks and the stock should be treated as a value trap, not a growth compounder.